Pentwater Capital Management LP Castle Biosciences Inc Transaction History

Pentwater Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $300,650 - $388,000	-5,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $169,286 - $259,593	-3,381 Reduced 40.34%	5,000 $367,000
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $95,391 - $157,577	-1,619 Reduced 16.19%	8,381 $574,000
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $218,000 - $365,250	5,000 Added 100.0%	10,000 $672,000
Q3 2020 Nov 16, 2020	SELL	$38.47 - $52.03 $96,175 - $130,075	-2,500 Reduced 33.33%	5,000 $257,000

Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $204,600 - $322,575	7,500 New	7,500 $283,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.